Carcinoma, Ductal - 30 Studies Found

Terminated : A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)
: Breast Carcinoma
: 2005-09-12
:
  • Drug: Tamoxifen 20mg
Completed : Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ
: Breast Cancer
: 2010-05-26
:
  • Genetic: RNA analysis
  • Genetic: gene expres
Not yet recruiting : Tamoxifen Citrate or Afimoxifene in Treating Patients With Estrogen Receptor Positive Breast Cancer
:
  • Ductal Breast Carcinoma In Situ
  • Estrogen Receptor Positive

    • : 2016-12-14
    :
    • Drug: Afimoxifene Applied to t
Recruiting : Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection
:
  • Breast Neoplasm
  • Carcinoma, Ductal, Breast
  • Procedure: Iron-tracer guided axillary ultrasound and biopsy

Recruiting : Contrast-Enhanced MRI in Women With Ductal Breast Carcinoma in Situ and in Healthy Volunteers
: Breast Cancer
: 2008-12-05
: Procedure: contrast-enhanced magnetic resonance imaging
Completed : Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy
:
  • Breast Neoplasms
  • Carcinoma, Ductal, Breast
  • Invasive Ductal Breast Cancer
  • Tubular Breast Cancer
  • : 2016-07-17
    :
    • Drug: Paclitaxel Other Name: T
Recruiting : Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients
:
  • Tubular Breast Cancer
  • Mucinous Breast Cancer
  • Drug: Paclitaxel Other Name: T
Completed : Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer
:
  • Tubular Breast Cancer
  • Mucinous Breast Cancer
  • Drug: Paclitaxel Other Name: T
Recruiting : BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer
:
  • Estrogen Receptor-positive Breast Cancer
  • HER2-negative Breast Cancer
  • Drug: PI3K inhibitor BYL719 Gi
<<< Previous